The International Initiative on Thrombosis and Cancer (ITAC-CME) is the international section of the Groupe Francophone Thrombose et Cancer (GFTC). GFTC is a clinical research organization that developed and published the first international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, as well as international clinical practice guidelines (CPG) for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer in 2013, using GRADE methodology. These CPGs, updated in 2016 and in 2019, are endorsed by the ISTH and are available through an internationally accessible free, web-based mobile application (app) which provids recommendations on the use of anticoagulants for the prevention and treatment of cancer-associated thrombosis. The app is available in English, French, and Spanish.
A multidisciplinary group, the members of ITAC-CME are clinicians and researchers from across the globe, led by a core group of GFTC members. The mandate of ITAC-CME is to reinforce the use of international treatments guidelines in clinical practice to improve patient outcomes and reduce unnecessary burden on healthcare budgets globally.